Dominant Dystrophic Epidermolysis Bullosa
4 clinical trials · Condition
◉ Watch Dominant Dystrophic Epidermolysis Bullosa
| Record | Firm | Date |
|---|---|---|
| A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa (NCT04917874) | Krystal Biotech, Inc. | 2021-05-25 |
| Long-Term Follow-up Protocol (NCT04917887) | Krystal Biotech, Inc. | 2021-05-25 |
| Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB (NCT04491604) | Krystal Biotech, Inc. | 2020-08-17 |
Track Dominant Dystrophic Epidermolysis Bullosa automatically
Every clearance here is in the API, with alerts when new ones post.